Expression microarray as a tool to identify differentially expressed genes in horses suffering from inflammatory airway disease

Veterinary Clinical Pathology

Volumn 44, Issue 1, 2015, Pages 37-46

  Ramery, Eve ^a   Fraipont, Audrey ^a   Richard, Eric A ^a,b,c   Art, Tatiana ^a   Pirottin, Dimitri ^a   van Delm, Wouter ^d   Bureau, Fabrice ^a   Lekeux, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Frank Duncombe Laboratory   (France)

^c Normandie Equine Vallée   (France)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Equine; Glutathione peroxidase; Inflammation; Oxidative stress; Respiratory

Indexed keywords

EQUIDAE;

GLUTATHIONE PEROXIDASE;

ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHUS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRANULOCYTE; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MALE; MAST CELL; METABOLISM; OXIDATIVE STRESS; PROSPECTIVE STUDY; VETERINARY;

ANIMALS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; GRANULOCYTES; HORSE DISEASES; HORSES; INFLAMMATION; MACROPHAGES; MALE; MAST CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PROSPECTIVE STUDIES;

EID: 84924229016     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/vcp.12216     Document Type: Article

References (35)

1. Pool DC. Current concepts of oxygen transport during exercise. Equine Comp Exerc Physiol. 2004;1:5-22.
2. Robinson NE, Hoffman AM. Inflammatory airway disease: defining the syndrome. Conclusions of the Havemeyer workshop. Equine Vet Educ. 2003;15:61-63.
3. Chapman PS, Green C, Main JP, et al. Retrospective study of the relationships between age, inflammation and the isolation of bacteria from the lower respiratory tract of thoroughbred horses. Vet Rec. 2000;146:91-95.
4. Wood JL, Newton JR, Chanter N, Mumford JA. Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses. Equine Vet J. 2005;37:236-242.
5. Couëtil LL, Hoffman AM, Hodgson J, et al. Inflammatory airway disease of horses. J Vet Intern Med. 2007;21:356-361.
6. Zieker D, Zieker J, Dietzsch J, Burnet M, Northoff H, Fehrenbach E. cDNA-microarray analysis as a research tool for expression profiling in human peripheral blood following exercise. Exerc Immunol Rev. 2005;11:86-96.
7. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
8. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
9. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21:2067-2075.
10. MAQC Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intra-platform reproducibility of gene expression measurements. Nat Biotechnol. 2006;4:1151-1161.
11. Richard EA, Fortier GD, Pitel PH, et al. Sub-clinical diseases affecting performance in Standardbreds: diagnostic methods and predictive parameters. Vet J. 2010;184:282-289.
12. Fraipont A, Van Erck E, Ramery E, et al. Subclinical diseases underlying poor performance in endurance horses: diagnostic methods and predictive tests. Vet Rec. 2011;169:154-161.
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289-300.
14. Bowton DL, Seeds MC, Fasano MB, Goldsmith B, Bass DA. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med. 1997;155:421-425.
15. De Marino V, Gentile M, Granata F, Marone G, Triggiani M. Secretory phospholipase A2: a putative mediator of airway inflammation. Int Arch Allergy Immunol. 1999;118:200-201.
16. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269:13057-13060.
17. Kirschvink N, de Moffarts B, Lekeux P. The oxidant/antioxidant equilibrium in horses. Vet J. 2008;177:178-191.
18. Dittrich AM, Meyer HA, Krokowski M, et al. Glutathione peroxidase-2 protects from allergen-induced airway inflammation in mice. Eur Respir J. 2010;35:1148-1154.
19. Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med. 2007;101:1670-1676.
20. Hu G, Zhou Y, Hong W, et al. Development and systematic oxidative stress of a rat model of chronic bronchitis and emphysema induced by biomass smoke. Exp Lung Res. 2013;39:229-240.
21. Quinlan T, Spivack S, Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect. 1994;102:79-87.
22. Dumitrascu R, Heitmann J, Seeger W, Weissmann N, Schulz R. Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies. Oxid Med Cell Longev. 2013;2013:234631.
23. Tomasetti C, Dell'Aversano C, Iasevoli F, De Bartolomeis A. Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. Neuroscience. 2007;150:144-158.
24. Grigorenko EL, De Young CG, Eastman M, et al. Aggressive behavior, related conduct problems, and variation in genes affecting dopamine turnover. Aggressive Behav. 2010;36:158-176.
25. Guillon G, Trueba M, Joubert D, et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology. 1995;136:1285-1295.
26. Koshimizu TA, Nasa Y, Tanoue A, et al. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA. 2006;103:7807-7812.
27. LeClerc S, Palaniswami R, Xie B, Govdan MV. Molecular cloning and characterization of a factor that binds the human glucocorticoid receptor gene and represses its expression. J Biol Chem. 1991;266:17333-17340.
28. Egerton A, Mehta MA, Montgomery AJ, et al. The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci Biobehav R. 2009;33:1109-1132.
29. Bermon S. Airway inflammation and upper respiratory tract infection in athletes: is there a link? Exerc Immunol Rev. 2007;13:6-14.
30. Vergès S, Devouassoux G, Flore P, et al. Bronchial hyperresponsiveness, airway inflammation, and airflow limitation in endurance athletes. Chest. 2005;127:1935-1941.
31. Bourgon R, Gentleman R, Huber W. Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci USA. 2010;21:9546-9551.
32. Efron B. Size, power and false discovery rates. Ann Stat. 2007;35:1351-1377.
33. Ramery E, Closset R, Bureau F, Art T, Lekeux P. Relevance of using a human microarray to study gene expression in heaves-affected horses. Vet J. 2008;177:216-221.
34. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J. 2005;19:1498-1500.
35. Zeibig J, Karlic H, Lohninger A, Damsgaard R, Smekal G. Do blood cells mimic gene expression profile alterations known to occur in muscular adaptation to endurance training? Eur J Appl Physiol. 2005;95:96-104.